Last Chance to Influence SUPAC Revisions!
In the Federal Register of March 3, 2026, the FDA published a request for information and comments on the Agency’s series of guidances for industry on Scale-Up and Post-Approval Changes (SUPAC) for specific dosage forms. Based on the requests received from interested parties, the FDA is reopening the comment period and extending it for an additional […]

